Literature DB >> 7586251

Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein.

F A Van Nieuwenhoven1, A H Kleine, W H Wodzig, W T Hermens, H A Kragten, J G Maessen, C D Punt, M P Van Dieijen, G J Van der Vusse, J F Glatz.   

Abstract

BACKGROUND: Myoglobin and fatty acid-binding protein (FABP) each are useful as early biochemical markers of muscle injury. We studied whether the ratio of myoglobin over FABP in plasma can be used to distinguish myocardial from skeletal muscle injury. METHODS AND
RESULTS: Myoglobin and FABP were assayed immunochemically in tissue samples of human heart and skeletal muscle and in serial plasma samples from 22 patients with acute myocardial infarction (AMI), from 9 patients undergoing aortic surgery (causing injury of skeletal muscles), and from 10 patients undergoing cardiac surgery. In human heart tissue, the myoglobin/FABP ratio was 4.5 and in skeletal muscles varied from 21 to 73. After AMI, the plasma concentrations of both proteins were elevated between approximately 1 and 15 to 20 hours after the onset of symptoms. In this period, the myoglobin/FABP ratio was constant both in subgroups of patients receiving and those not receiving thrombolytics and amounted to 5.3 +/- 1.2 (SD). In serum from aortic surgery patients, both proteins were elevated between 6 and 24 hours after surgery; the myoglobin/FABP ratio was 45 +/- 22 (SD), which is significantly different from plasma values in AMI patients (P < .001). In patients with cardiac surgery, the ratio increased from 11.3 +/- 4.7 to 32.1 +/- 13.6 (SD) during 24 hours after surgery, indicating more rapid release of protein from injured myocardium than from skeletal muscles.
CONCLUSIONS: The ratio of the concentrations of myoglobin over FABP in plasma from patients with muscle injury reflects the ratio found in the affected tissue. Since this ratio is different between heart (4.5) and skeletal muscle (20 to 70), its assessment in plasma allows the discrimination between myocardial and skeletal muscle injury in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586251     DOI: 10.1161/01.cir.92.10.2848

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Plasma biomarkers for neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Ryan D Geraets; Krystal L Weber; Chun-Hung Chan; David A Pearce
Journal:  FEBS J       Date:  2015-12-17       Impact factor: 5.542

2.  Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates.

Authors:  Florian Guthmann; Torsten Börchers; Christian Wolfrum; Thomas Wustrack; Sabine Bartholomäus; Friedrich Spener
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

3.  Serum complements and heart fatty acid binding protein in Bangladeshi patients with acute myocardial infarction.

Authors:  Nayareen Akhtar; Abu Taher; Rezwanur Rahman; Ashesh Kumar Chowdhury
Journal:  Heart Asia       Date:  2012-09-26

4.  Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke.

Authors:  Michael T Wunderlich; Thorsten Hanhoff; Michael Goertler; Friedrich Spener; Jane F C Glatz; Claus-W Wallesch; Maurice M A L Pelsers
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

5.  Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction.

Authors:  Chun-jian Li; Jie-qi Li; Xiao-fang Liang; Xiao-xiang Li; Jian-guo Cui; Zhi-jian Yang; Qing Guo; Ke-jiang Cao; Jun Huang
Journal:  Acta Pharmacol Sin       Date:  2010-02-05       Impact factor: 6.150

Review 6.  Fatty acid-binding proteins in the heart.

Authors:  F G Schaap; G J van der Vusse; J F Glatz
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

7.  Value of heart-type fatty acid-binding protein (H-FABP) for emergency department patients with suspected acute coronary syndrome.

Authors:  Karakus Yilmaz Banu; Ozüçelik Doğaç Niyazi; Cevik Erdem; Doğan Hatice Dpekçi Afşin; Uzun Ozlem; Celik Yasemin; Ipekci Afsin
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

8.  Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome.

Authors:  Hafidh A Al-Hadi; Keith A Fox
Journal:  Sultan Qaboos Univ Med J       Date:  2009-12-19

9.  Antioxidant network expression abrogates oxidative posttranslational modifications in mice.

Authors:  R Mital; W Zhang; M Cai; Z M Huttinger; L A Goodman; D G Wheeler; M T Ziolo; K M Dwyer; A J F d'Apice; J L Zweier; G He; P J Cowan; R J Gumina
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

10.  Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein.

Authors:  S Sorichter; J Mair; A Koller; M M Pelsers; B Puschendorf; J F Glatz
Journal:  Br J Sports Med       Date:  1998-06       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.